Photo from Sara Tolaney/Twitter
Aug 25, 2023, 18:26
Sara Tolaney: TROPICS-02 Overall Survival data now published in The Lancet!
Quoting Sara Tolaney, Chief of Division of Breast Oncology at Dana Farber Cancer Institute, on X/Twitter:
”TROPICS-02 Overall Survival data now published in The Lancet!
Sacituzumab govitecan improved PFS, ORR, OS, & QOL c/w TPC in pts with pretreated metastatic HR+ BC. Benefit seen across all Trop-2 exp levels.”
For the article click here.
Source: Sara Tolaney/Twitter
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 1, 2025, 14:35
Apr 1, 2025, 14:08
Apr 1, 2025, 12:48
Apr 1, 2025, 12:16
Apr 1, 2025, 12:13